Barorezeptorakivierungstherapie bei therapierefraktärer Hypertonie: Indikation und Patientenselektion

Autor: N. Mader, H.-G. Predel, Georg Schlieper, J. Börgel, S. Lüders, Manuel Wallbach, S. Parmentier, Dieter Zenker, J. Müller-Ehmsen, Bernhard K. Krämer, Felix Mahfoud, Vedat Schwenger, G. Henning, Marcel Halbach, Hannes Reuter, Martin Hausberg, Oliver Vonend, J. Passauer, M. Lodde, M. van der Giet, Florian P. Limbourg, Joachim Beige, S. Büttner, Michael Koziolek, Jens Jordan
Rok vydání: 2017
Předmět:
Zdroj: Der Internist. 58:1114-1123
ISSN: 1432-1289
0020-9554
DOI: 10.1007/s00108-017-0308-y
Popis: Baroreceptor activation therapy (BAT) has been available for several years for treatment of therapy-refractory hypertension (trHTN). This procedure is currently being carried out in a limited number of centers in Germany, also with the aim of offering a high level of expertise through sufficient experience; however, a growing number of patients who are treated with BAT experience problems that treating physicians are confronted with in routine medical practice. In order to address these problems, a consensus conference was held with experts in the field of trHTN in November 2016, which summarizes the current evidence and experience as well as the problem areas in handling BAT patients.
Databáze: OpenAIRE
Externí odkaz: